7 How GLP-1 drugs may reshape addiction pathways GLP-1 RAs interact with the mammalian mesolimbic reward system and have been proposed to modulate dopaminergic signaling in circuits involving the ventral tegmental area, nucleus accumbens, and other reward-related regions, thereby reducing the reinforcing value of food and some substances in preclinical models
Such complexity acts as a speed bump urging caution and regulation
Moreover, the overproduction of ROS and free radicals results in lung injury and increases the risk of critical illness in COVID-19
The most commonly reported side effects in Retatrutide trials were gastrointestinal in nature, including nausea, diarrhoea, vomiting, and constipation
Song, C., Long, X., He, J
One 10 mg vial lasts exactly 4 weeks at 2.5 mg per week